Article
GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated…
medRxiv · 2025 · Bogacki, E. C.; Longmore, G.; Lewis, P. A.; Herbst, S.
Key facts
| Title | GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis |
|---|---|
| First author | Bogacki, E. C.; Longmore, G.; Lewis, P. A.; Herbst, S. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.01.01.630988 |
| Devices mentioned | BK110039, DEN000008, K022086, K032692, K041074, K103302, K912666 |
| Product codes mentioned | GKZ, JZG, LIQ, NDS, PCA, JCI, KIT, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1